Newest first. 5.2k questions across 107 tags.
I understand the single-missed-dose instructions. What I cannot find a clear derivation for is the longer break. The weight-management labels in this class address…
The case in front of me: Xi’an · Ireland. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
What I have: 2 mg/mL · dulaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
What I have: mazdutide · sixteen weeks · minus 20 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
Setup, so nobody has to ask: Medutest · orforglipron. I would like to understand the steps well enough to explain them to someone else. I have access to a…
Numbers first: a 1 mL luer-lock syringe · 2.5 mg · 4 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay…
Setup, so nobody has to ask: GGT · four weeks · retatrutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I…
The case in front of me: STEP 2 · 1 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Concretely: semaglutide · twelve weeks · minus 80 °C. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the…
Concretely: STEP 8 · 2.4 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
Conditions: 1 mg · four weeks · early satiety. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically,…
The method section is present, which is unusual enough that I want to make use of it. I want the working, not the result — I need to be able to redo it with different…
Details up front: an escrowed payment · Germany. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I…
For context, I am working with a 10 mg presentation and a 2 mL fill. I want the working, not the result — I need to be able to redo it with different numbers. I care…
The case in front of me: VendorInvestigate · Sangon Biotech (Shanghai). The figures are clear enough; the question is what they mean and what they do not. I can…
Conditions: 2.5 mg · 0.5 mL · 0.9% sodium chloride · a GLP-1 receptor agonist. I want to decide this in advance so that I am not deciding it under pressure later.…
What I have: HJ · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Concretely: TFC · liraglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
Setup, so nobody has to ask: tirzepatide · semaglutide. I am trying to choose between two options that are usually discussed as though only one exists. I am not…
Conditions: semaglutide · ESSENCE. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that come up…
For reference: minus 80 °C · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
The lane and the lead time matter as much as the material for what I am doing. I am at the decision point and I would rather think it through than improvise. I would…
The particulars: 97.1% · list of related substances. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
Stated plainly: 97.9% · Medutest · 95.2%. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded anything…